London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M (Ingrid Lunden/TechCrunch)



Ingrid Lunden / TechCrunch:

London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M  —  Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery.



Check Also

Sources detail Apple's $10B+ car project: years of disagreements on whether it should be a self-driving car or just an EV, talks with Musk on buying Tesla, more (New York Times)

New York Times: Sources detail Apple’s $10B+ car project: years of disagreements on whether it …